Verve Therapeutics Inc (VERV)
6.16
-0.06
(-0.96%)
USD |
NASDAQ |
Apr 26, 16:00
6.155
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Free Cash Flow: -158.83M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -158.83M |
| September 30, 2023 | -153.83M |
| June 30, 2023 | -172.77M |
| March 31, 2023 | -151.62M |
| December 31, 2022 | -135.56M |
| September 30, 2022 | -126.73M |
| June 30, 2022 | -117.27M |
| Date | Value |
|---|---|
| March 31, 2022 | -102.44M |
| December 31, 2021 | -82.24M |
| September 30, 2021 | -69.14M |
| June 30, 2021 | -54.13M |
| March 31, 2021 | -47.02M |
| December 31, 2020 | -38.69M |
Free Cash Flow Range, Past 5 Years
-172.77M
Minimum
Jun 2023
-38.69M
Maximum
Dec 2020
-108.48M
Average
-117.27M
Median
Jun 2022
Free Cash Flow Benchmarks
| Acorda Therapeutics Inc | -14.25M |
| Eli Lilly and Co | -3.152B |
| Intellia Therapeutics Inc | -408.07M |
| Beam Therapeutics Inc | -182.93M |
| Gritstone Bio Inc | -126.22M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -40.68M |
| Cash from Investing (Quarterly) | -8.893M |
| Cash from Financing (Quarterly) | 177.38M |
| Free Cash Flow Per Share (Quarterly) | -0.5229 |
| Free Cash Flow to Equity (Quarterly) | -42.86M |
| Free Cash Flow to Firm (Quarterly) | -42.86M |
| Free Cash Flow Yield | -38.35% |